News Clips & Coverage

[Excerpt]
1986 Gregory J. Glover, a pharmaceutical intellectual property attorney, is the author of “Regulatory IP: Essentials of Lifecycle Management for Pharmaceutical and Biotechnology Products.” This resource for
scientists, drug sponsors, investors, and other pharmaceutical industry pros includes accessible knowledge and insights on patent protection, FDA regulation, and manufacturing criteria.

Last year, the FDA vowed to boost its efforts to advance the development of new gene therapies. To support innovation, the agency said, it had already approved three gene therapy products while also issuing valuable guidance for players in the field.
Gene therapy is a technique used to treat certain disorders by inserting a gene into a patient’s cells rather than resorting to riskier and often less effective drugs or surgery. Current regulations establish that research involving...